oseltamivir has been researched along with Acute Liver Injury, Drug-Induced in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Grundmark, B; Vidlin, SH; Watson, S; Zekarias, A | 1 |
| Bennasroune, A; Blaise, S; Bocquet, O; Boulagnon, C; Duca, L; Fougerat, A; Gayral, S; Gillery, P; Henry, A; Jaisson, S; Laffargue, M; Martiny, L; Maurice, P; Romier-Crouzet, B; Sarazin, T; Sartelet, H; Schneider, C; Vincent, E; Wahart, A | 1 |
| Fang, S; Li, C; Qi, L; Zhou, N | 1 |
1 review(s) available for oseltamivir and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for oseltamivir and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.
Topics: Abdominal Pain; Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Chemical and Drug Induced Liver Injury; Chloroquine; COVID-19 Drug Treatment; Databases, Pharmaceutical; Diarrhea; Drug Combinations; Drug Eruptions; Drug Repositioning; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Male; Nausea; Oseltamivir; Ritonavir; Sex Distribution; Sex Factors; Vomiting | 2020 |
Adverse Effects of Oseltamivir Phosphate Therapy on the Liver of LDLR-/- Mice Without Any Benefit on Atherosclerosis and Thrombosis.
Topics: Animals; Antiviral Agents; Aorta; Aortic Diseases; Atherosclerosis; Carotid Artery Thrombosis; Chemical and Drug Induced Liver Injury; Diet, High-Fat; Disease Models, Animal; Female; Liver; Liver Cirrhosis; Mice, Knockout; Oseltamivir; Plaque, Atherosclerotic; Receptors, LDL; Risk Assessment | 2021 |
Case report on alimentary tract hemorrhage and liver injury after therapy with oseltamivir: A case report.
Topics: Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Child; Digestive System Diseases; Gastrointestinal Hemorrhage; Gastrointestinal Tract; Hepatitis; Humans; Male; Oseltamivir | 2018 |